These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10196915)

  • 1. Analgesics in the management of chronic pain. Part four: Step 3 oral analgesic drug therapy.
    MacConnachie AM
    Intensive Crit Care Nurs; 1998 Dec; 14(6):318-9. PubMed ID: 10196915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New option in the management of cancer pain in Hungary: short acting oral opioid therapy].
    Kullmann T; Sipőcz I; Csikós Á; Pintér T
    Orv Hetil; 2015 Jun; 156(25):1003-6. PubMed ID: 26170088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
    Collins JJ; Geake J; Grier HE; Houck CS; Thaler HT; Weinstein HJ; Twum-Danso NY; Berde CB
    J Pediatr; 1996 Nov; 129(5):722-8. PubMed ID: 8917240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is your gut feeling about opioid rotation?
    Didwaniya N; Reddy A; Gottumukkala RS; Bruera E
    J Clin Oncol; 2015 Jan; 33(3):e11-2. PubMed ID: 24590650
    [No Abstract]   [Full Text] [Related]  

  • 5. Contribution to variability in response to opioids.
    Hanks GW; Reid C
    Support Care Cancer; 2005 Mar; 13(3):145-52. PubMed ID: 15761703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.
    Coluzzi F; Mattia C
    Minerva Anestesiol; 2010 Dec; 76(12):1072-84. PubMed ID: 21102402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
    Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
    Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA.
    Dunbar PJ; Chapman CR; Buckley FP; Gavrin JR
    Pain; 1996 Dec; 68(2-3):265-70. PubMed ID: 9121813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Pharmacokinetics-Pharmacodynamics: Clinical Implications in Acute Pain Management in Trauma.
    MacKenzie M; Zed PJ; Ensom MH
    Ann Pharmacother; 2016 Mar; 50(3):209-18. PubMed ID: 26739277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal morphine for chronic benign pain.
    Gerber HR
    Best Pract Res Clin Anaesthesiol; 2003 Sep; 17(3):429-42. PubMed ID: 14529012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydromorphone.
    Pasero C; McCaffery M
    Am J Nurs; 2001 Feb; 101(2):22-3. PubMed ID: 11227223
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydromorphone: pharmacology and clinical applications in cancer patients.
    Sarhill N; Walsh D; Nelson KA
    Support Care Cancer; 2001 Mar; 9(2):84-96. PubMed ID: 11305075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in medical use and abuse of opioid analgesics.
    Joranson DE; Ryan KM; Gilson AM; Dahl JL
    JAMA; 2000 Apr; 283(13):1710-4. PubMed ID: 10755497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacotherapy of chronic, non-tumour related pain. Efficacy, tolerability and patient benefit of an oral osmotic system with hydromorphone].
    Sabatowski R; Giesecke T
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():119-24. PubMed ID: 17955789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydromorphone for acute and chronic pain.
    Quigley C
    Cochrane Database Syst Rev; 2002; (1):CD003447. PubMed ID: 11869661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain.
    Palangio M; Northfelt DW; Portenoy RK; Brookoff D; Doyle RT; Dornseif BE; Damask MC
    J Pain Symptom Manage; 2002 May; 23(5):355-68. PubMed ID: 12007754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of hydromorphone in acute and chronic pain.
    Quigley C; Wiffen P
    J Pain Symptom Manage; 2003 Feb; 25(2):169-78. PubMed ID: 12590032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.